NDC 33332-125-10
Afluria 15 ug/.5mL
INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED) · INJECTION, SUSPENSION
Afluria is a injection, suspension containing influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (propiolactone inactivated), influenza a virus a/croatia/10136rv/2023 x-425a (h3n2) antigen (propiolactone inactivated), influenza b virus b/austria/1359417/2021 bvr-26 antigen (propiolactone inactivated) at a strength of 15 ug/.5mL. Manufactured by Seqirus PTY LTD..
Key Facts
- Brand Name
- Afluria
- Generic Name
- INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED)
- NDC Code (Package)
33332-125-10- NDC Code (Product)
33332-125- Manufacturer
- Seqirus PTY LTD.
- Strength
- 15 ug/.5mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125254
- Marketing Start
- 07/01/2025
Recall History
No Recall HistoryView Full Drug Page
Afluria — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.